Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana-Maria Henao-Restrepo

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Vaccine|February 14, 2012
Comparing pneumococcal conjugate vaccine schedules in infancyNicola Low, Pippa Scott, Ana Maria Henao Restrepo
Vaccine|December 18, 2007
Immunogenicity and safety of aerosolized measles vaccine: systematic review and meta-analysisNicola Low, Sibylle Kraemer, Martin Schneider, et al.
Bulletin of the World Health Organization|March 6, 2020
Data sharing for novel coronavirus (COVID-19)Vasee Moorthy, Ana Maria Henao Restrepo, Marie-Pierre Preziosi, et al.
The Journal of Infectious Diseases|May 2, 2003
Experience in global measles control, 1990-2001Ana-Maria Henao-Restrepo, Peter Strebel, Edward John Hoekstra, et al.
Lancet (London, England)|August 31, 2020
COVID-19 vaccine trials should seek worthwhile efficacyPhilip Krause, Thomas R Fleming, Ira Longini, et al.
Lancet (London, England)|October 30, 2020
Maintaining confidentiality of emerging results in COVID-19 vaccine trials is essentialPhilip R Krause, Thomas R Fleming, Susan S Ellenberg, et al.
Current Opinion in Virology|May 16, 2016
On a path to accelerate access to Ebola vaccines: The WHO's research and development efforts during the 2014-2016 Ebola epidemic in West AfricaAna Maria Henao-Restrepo, Marie-Pierre Preziosi, David Wood, et al.
The Journal of Infectious Diseases|May 2, 2003
Determining measles-containing vaccine demand and supply: an imperative to support measles mortality reduction effortsAlejandro Costa, Ana-Maria Henao-Restrepo, Shanelle Marie Hall, et al.
Lancet (London, England)|March 27, 2022
Booster vaccines for COVID-19 vaccine breakthrough cases? - Authors' replyPhilip R Krause, Helen Rees, J Peter Figueroa, et al.
Lancet (London, England)|January 8, 2016
Ebola vaccination - Authors' replyIra M Longini, Matthias Egger, Natalie E Dean, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Vaccine|February 14, 2012
Comparing pneumococcal conjugate vaccine schedules in infancyNicola Low, Pippa Scott, Ana Maria Henao Restrepo
Vaccine|December 18, 2007
Immunogenicity and safety of aerosolized measles vaccine: systematic review and meta-analysisNicola Low, Sibylle Kraemer, Martin Schneider, et al.
Bulletin of the World Health Organization|March 6, 2020
Data sharing for novel coronavirus (COVID-19)Vasee Moorthy, Ana Maria Henao Restrepo, Marie-Pierre Preziosi, et al.
The Journal of Infectious Diseases|May 2, 2003
Experience in global measles control, 1990-2001Ana-Maria Henao-Restrepo, Peter Strebel, Edward John Hoekstra, et al.
Lancet (London, England)|August 31, 2020
COVID-19 vaccine trials should seek worthwhile efficacyPhilip Krause, Thomas R Fleming, Ira Longini, et al.
Lancet (London, England)|October 30, 2020
Maintaining confidentiality of emerging results in COVID-19 vaccine trials is essentialPhilip R Krause, Thomas R Fleming, Susan S Ellenberg, et al.
Current Opinion in Virology|May 16, 2016
On a path to accelerate access to Ebola vaccines: The WHO's research and development efforts during the 2014-2016 Ebola epidemic in West AfricaAna Maria Henao-Restrepo, Marie-Pierre Preziosi, David Wood, et al.
The Journal of Infectious Diseases|May 2, 2003
Determining measles-containing vaccine demand and supply: an imperative to support measles mortality reduction effortsAlejandro Costa, Ana-Maria Henao-Restrepo, Shanelle Marie Hall, et al.
Lancet (London, England)|March 27, 2022
Booster vaccines for COVID-19 vaccine breakthrough cases? - Authors' replyPhilip R Krause, Helen Rees, J Peter Figueroa, et al.
Lancet (London, England)|January 8, 2016
Ebola vaccination - Authors' replyIra M Longini, Matthias Egger, Natalie E Dean, et al.
Pageof 5